The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer.
Szpechcinski A, Moes-Sosnowska J, Skronska P, Lechowicz U, Pelc M, Szolkowska M, Rudzinski P, Wojda E, Maszkowska-Kopij K, Langfort R, Orlowski T, Sliwinski P, Polaczek M, Chorostowska-Wynimko J.
Szpechcinski A, et al. Among authors: orlowski t.
Int J Mol Sci. 2024 Jul 19;25(14):7908. doi: 10.3390/ijms25147908.
Int J Mol Sci. 2024.
PMID: 39063150
Free PMC article.